Tritriacont - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

94386-36-4

Acetic acid, 2-sulfo-,1-(3,6,9,12,15-pentaoxaTritriacont-24-en-1-yl) ester, sodium salt (1:1);
Aceticacid, sulfo-, 1-(3,6,9,12,15-pentaoxaTritriacont-24-en-1-yl) ester, monosodiumsalt (9CI)

Bouvardin,5-(N-methyl-L-tyrosine)-6-(3-hydroxy-N,O-dimethyl-L-tyrosine)- (9CI);
22-Oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.218,21.123,27]Tritriacontane,cyclic peptide deriv.;
RA 700;
RA VII;
TPC-B

Bouvardin,5-(N-methyl-L-tyrosine)- (9CI);
22-Oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.218,21.123,27]Tritriacontane,cyclic peptide deriv.;
Bouvardin, deoxy-;
Deoxybouvardin;
NSC 259969;
RA V;
TPC-A

Bouvardin,3-(N-methyl-L-tyrosine)- (9CI);
22-Oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.218,21.123,27]Tritriacontane,cyclic peptide deriv.;
NSC 324579

Bouvardin (9CI);
22-Oxa-3,6,9,12,15,29-hexaazatetracyclo[14.12.2.218,21.123,27]Tritriacontane,cyclic peptide deriv.;
(S)-Cyclo(D-alanyl-L-alanyl-N,O-dimethyl-L-tyrosyl-L-alanyl-b-hydroxy-N-methyl-L-tyrosyl-3-hydroxy-N-methyl-L-tyrosyl)cyclic (54®
63)-ether;
Cyclo(D-alanyl-L-alanyl-N,O-dimethyl-L-tyrosyl-L-alanyl-b-hydroxy-N-methyl-L-tyrosyl-3-hydroxy-N-methyl-L-tyrosyl),cyclic (54®
63)-ether, (S)-;
NSC 259968

Cyclosporin A,2-[N6-[4-(1-diazo-2,2,2-trifluoroethyl)benzoyl]-D-lysine]- (9CI);
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane,cyclic peptide deriv.

Cyclosporin G,6-[(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3-hydroxy-N,4-dimethyl-L-2-aminooctanoic acid]-7-L-norvaline-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclic peptidederiv.;
Cyclosporin G, dihydro-;
Dihydrocyclosporin G

Cyclosporin A,8-(N-methyl-D-serine)-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane,cyclic peptide deriv.;
SDZ 209-313

Cyclosporin V (9CI);
CyclosporinA, 1-(L-2-aminobutanoic acid)-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclic peptidederiv.;
Cyclo[D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-2-aminobutanoyl]

Cyclosporin A,6-[(2E,5R,6R,7S)-6-hydroxy-5-methyl-7-(methylamino)-2-octenedioic acid]-;
CyclosporinA, 6-[(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanedioicacid]-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclicpeptide deriv.;
AM 1A;
Cyclosporin A metabolite 203-218;
M 203-218

Cyclosporin B,6-[(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3-hydroxy-N,4-dimethyl-L-2-aminooctanoic acid]-7-L-alanine-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclic peptidederiv.;
Cyclosporin B, dihydro-;
Dihydrocyclosporin B

Cyclosporin A,6-[(2S,3R,4R,6E)-3-(acetyloxy)-4-methyl-2-(methylamino)-6-octenoic acid]-;
CyclosporinA, acetate (ester) (9CI);
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclic peptidederiv.;
B 3-243;
O-Acetyl-C91-cyclosporin A;
O-Acetylcyclosporin A;
SDZ 33-243

Cyclosporin A,6-[(2S,3R,4R)-3,8-dihydroxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3,8-dihydroxy-N,4-dimethyl-L-2-aminooctanoic acid]-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclic peptidederiv.;
AM 1D1

Cyclosporin A,6-[(2S,3R,6E)-3-hydroxy-4,4-dimethyl-2-(methylamino)-6-octenoic acid]- (9CI);
CyclosporinA, 6-[(3R,6E)-6,7-didehydro-3-hydroxy-N,4,4-trimethyl-L-2-aminooctanoic acid]-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclic peptidederiv.;
L 674184

Cyclosporin A,9-(N-methyl-L-isoleucine)-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane,cyclic peptide deriv.;
NIM 811;
SDZ-NIM 811

Cyclosporin A,6-[(2S,3R,4R)-3-hydroxy-8-methoxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3-hydroxy-8-methoxy-N,4-dimethyl-L-2-aminooctanoic acid]-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclic peptidederiv.;
SDZ 205-549

Cyclosporin A,2-[O-(2-hydroxyethyl)-D-serine]-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane,cyclic peptide deriv.;
Cyclo[[(2S,3R,4R,6E)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-O-(2-hydroxyethyl)-D-seryl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl];
IMM 125;
Oxeclosporin;
SDZ-IMM 125

Cyclosporin A,6-[(2S,3R,4R,6E)-3,8-dihydroxy-4-methyl-2-(methylamino)-6-octenoic acid]-;
CyclosporinA, 6-[(3R,4R,6E)-6,7-didehydro-3,8-dihydroxy-N,4-dimethyl-L-2-aminooctanoicacid]-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclicpeptide deriv.;
7: PN: US6686454 SEQID: 7 claimed protein;
AM 1;
AM 1(peptide);
Cyclosporin A metabolite 17;
Cyclosporin AM 1;
Cyclosporinmetabolite 17;
M 17;
OL 17

Cyclosporin A,11-(N-methyl-L-alanine)-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane,cyclic peptide deriv.;
L 665890;
W 0-039

Cyclosporin D,6-[(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)octanoic acid]- (9CI);
CyclosporinA, 6-[(3R,4R)-3-hydroxy-N,4-dimethyl-L-2-aminooctanoic acid]-7-L-valine-;
1,4,7,10,13,16,19,22,25,28,31-UndecaazacycloTritriacontane, cyclic peptidederiv.;
Cyclosporin D, dihydro-;
Dihydrocyclosporin D

C63H115N11O12

详情

供应商

化工产品